Published in Lancet on August 17, 1991
Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin Microbiol Rev (2000) 3.69
Recognising serious illness in feverish young children in primary care. BMJ (2007) 3.44
Rapid diagnosis of acute meningococcal infections by needle aspiration or biopsy of skin lesions. BMJ (1993) 1.65
Smoking, the environment and meningococcal disease: a case control study. Epidemiol Infect (1994) 1.62
A population based study of the impact of corticosteroid therapy and delayed diagnosis on the outcome of childhood pneumococcal meningitis. Arch Dis Child (2005) 1.59
Recognizing meningococcal disease: the case for further research in primary care. Br J Gen Pract (1998) 1.51
Clinical data and factors associated with poor outcome in pneumococcal meningitis. Eur J Pediatr (2005) 1.45
Bacterial meningitis in Swaziland: an 18 month prospective study of its impact. J Epidemiol Community Health (1994) 0.95
Cerebrospinal fluid levels of interleukin-6 and interleukin-12 in children with meningitis. Childs Nerv Syst (2008) 0.81
Clinical characteristics and prognostic factors in childhood bacterial meningitis: a multicenter study. Balkan Med J (2013) 0.81
Current Concepts of Therapy for Otitis Media. Curr Infect Dis Rep (1999) 0.75
Meningitis. J Neurol Neurosurg Psychiatry (1994) 0.75
SEQAID: a DNA sequence assembling program based on a mathematical model. Nucleic Acids Res (1984) 6.91
Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland. Pediatrics (1977) 4.64
Meningococcal disease: still with us. Rev Infect Dis (1983) 4.36
The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis (1983) 4.05
Prevention of Hemophilus influenzae type b bacteremic infections with the capsular polysaccharide vaccine. N Engl J Med (1984) 3.37
Randomised comparison of chloramphenicol, ampicillin, cefotaxime, and ceftriaxone for childhood bacterial meningitis. Finnish Study Group. Lancet (1989) 3.33
Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age. N Engl J Med (1977) 3.32
A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease. N Engl J Med (1990) 2.90
Polysaccharide vaccines of group A Neisseria meningtitidis and Haemophilus influenzae type b: a field trial in Finland. J Infect Dis (1977) 2.79
Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in infancy. N Engl J Med (1987) 2.47
Reversal of the sedative and sympatholytic effects of dexmedetomidine with a specific alpha2-adrenoceptor antagonist atipamezole: a pharmacodynamic and kinetic study in healthy volunteers. Anesthesiology (1998) 2.44
Rapid disappearance of Haemophilus influenzae type b meningitis after routine childhood immunisation with conjugate vaccines. Lancet (1992) 2.38
Frequency of true adverse reactions to measles-mumps-rubella vaccine. A double-blind placebo-controlled trial in twins. Lancet (1986) 2.34
Rapid effect on endemic measles, mumps, and rubella of nationwide vaccination programme in Finland. Lancet (1986) 2.21
Vaccination greatly reduces disease, disability, death and inequity worldwide. Bull World Health Organ (2008) 2.16
Trimethoprim. Pharmacology, antimicrobial activity and clinical use in urinary tract infections. Ann Clin Res (1978) 2.07
No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study. Lancet (1998) 2.01
Simplified treatment of acute staphylococcal osteomyelitis of childhood. The Finnish Study Group. Pediatrics (1997) 1.86
Measles history and atopic diseases: a population-based cross-sectional study. JAMA (2000) 1.81
Use of fluoroquinolones in pediatrics: consensus report of an International Society of Chemotherapy commission. Pediatr Infect Dis J (1995) 1.70
Antibody response to capsular polysaccharides of groups A and C neisseria meningitidis and Haemophilus influenzae type b during bacteremic disease. J Infect Dis (1981) 1.65
Serum antibodies after vaccination with Haemophilus influenzae type b capsular polysaccharide and responses to reimmunization: no evidence of immunologic tolerance or memory. Pediatrics (1984) 1.65
Hyaluronan in human malignancies. Exp Cell Res (2010) 1.63
Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up. Pediatr Infect Dis J (2000) 1.56
Serum antibodies to capsular polysaccharide vaccine of group A Neissera meningitidis followed for three years in infants and children. J Infect Dis (1980) 1.53
Antibody levels achieved in infants by course of Haemophilus influenzae type B polysaccharide/diphtheria toxoid conjugate vaccine. Lancet (1985) 1.52
Narrow- versus broad-spectrum parenteral anatimicrobials against common infections of childhood: a prospective and randomised comparison between penicillin and cefuroxime. Eur J Pediatr (2000) 1.51
Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection. J Med Virol (1998) 1.48
The effect of a recent previous visit to a physician on outcome after childhood bacterial meningitis. JAMA (1994) 1.48
Serum C-reactive protein, erythrocyte sedimentation rate, and white blood cell count in acute hematogenous osteomyelitis of children. Pediatrics (1994) 1.40
Meningococcal disease in Scandinavia. Br Med J (Clin Res Ed) (1982) 1.35
Meningococcal disease in Europe: epidemiology, mortality, and prevention with conjugate vaccines. Report of a European advisory board meeting Vienna, Austria, 6-8 October, 2000. Vaccine (2001) 1.34
Evaluation of two tetravalent (ACYW135) meningococcal vaccines in infants and small children: a clinical study comparing immunogenicity of O-acetyl-negative and O-acetyl-positive group C polysaccharides. Pediatrics (1985) 1.34
Changes in erythrocyte sedimentation rate and C-reactive protein after total hip arthroplasty. Clin Orthop Relat Res (1984) 1.31
Serum C-reactive protein, erythrocyte sedimentation rate and white blood cell count in septic arthritis of children. Pediatr Infect Dis J (1997) 1.28
Human pharmacokinetics of sotalol. Acta Pharmacol Toxicol (Copenh) (1976) 1.27
C-reactive protein in rapid differentiation of acute epiglottitis from spasmodic croup and acute laryngotracheitis: a preliminary report. J Pediatr (1983) 1.25
Seasonal variation in etiology of travelers' diarrhea. Finnish-Moroccan Study Group. J Infect Dis (1992) 1.22
Shift in the age-distribution of meningococcal disease as predictor of an epidemic? Lancet (1982) 1.21
Epidemiology of invasive Haemophilus influenzae type b disease among children in Finland before vaccination with Haemophilus influenzae type b conjugate vaccine. Pediatr Infect Dis J (1989) 1.20
Antihypertensive effects of practolol and sotalol. Clin Pharmacol Ther (1974) 1.20
Etiology of measles- and rubella-like illnesses in measles, mumps, and rubella-vaccinated children. J Infect Dis (1998) 1.20
Vaccination against meningococcal group A disease in Finland 1974-75. Scand J Infect Dis (1976) 1.19
Group A meningococcal polysaccharide vaccine and course of the group A meningococcal epidemic in Finland. Scand J Infect Dis (1978) 1.19
Childhood bacterial meningitis: initial symptoms and signs related to age, and reasons for consulting a physician. Eur J Pediatr (1987) 1.19
Trips to the South--a health hazard. Morbidity of Finnish travellers. Scand J Infect Dis (1983) 1.17
Clinical effects and pharmacokinetics of medetomidine and its enantiomers in dogs. J Vet Pharmacol Ther (2000) 1.16
C reactive protein in the evaluation of febrile illness. Arch Dis Child (1986) 1.16
Short-term treatment of traveler's diarrhea with norfloxacin: a double-blind, placebo-controlled study during two seasons. Clin Infect Dis (1993) 1.15
Oral glycerol and intravenous dexamethasone in preventing neurologic and audiologic sequelae of childhood bacterial meningitis. The Finnish Study Group. Pediatr Infect Dis J (1995) 1.14
Reappraisal of lung tap: review of an old method for better etiologic diagnosis of childhood pneumonia. Clin Infect Dis (2001) 1.11
Secondary measles vaccine failures identified by measurement of IgG avidity: high occurrence among teenagers vaccinated at a young age. Epidemiol Infect (2000) 1.10
Explosive school-based measles outbreak: intense exposure may have resulted in high risk, even among revaccinees. Am J Epidemiol (1998) 1.10
Clinical "pneumococcal pneumonia" due to Moraxella osloensis: case report and a review. Scand J Infect Dis (2001) 1.09
Prognostic significance of matrix metalloproteinase-9 (MMP-9) in epithelial ovarian cancer. Gynecol Oncol (2006) 1.09
Local immune responses to Chlamydia pneumoniae in the lungs of BALB/c mice during primary infection and reinfection. Infect Immun (1998) 1.09
Fever, C-reactive protein, and erythrocyte sedimentation rate in monitoring recovery from septic arthritis: a preliminary study. J Pediatr Orthop (1984) 1.08
C-reactive protein compared with white blood cell count and erythrocyte sedimentation rate in the diagnosis of acute appendicitis in children. Acta Chir Scand (1986) 1.06
Immunogenicity in infants of a vaccine composed of Haemophilus influenzae type b capsular polysaccharide mixed with DPT or conjugated to diphtheria toxoid. J Infect Dis (1987) 1.06
Successful shortening from seven to four days of parenteral beta-lactam treatment for common childhood infections: a prospective and randomized study. Int J Infect Dis (2001) 1.05
Pneumococcal conjugate vaccines. Pediatr Infect Dis J (1999) 1.05
Neonatal Candida parapsilosis outbreak with a high case fatality rate. Pediatr Infect Dis J (1995) 1.05
Meningococcus group A vaccine in children three months to five years of age. Adverse reactions and immunogenicity related to endotoxin content and molecular weight of the polysaccharide. J Pediatr (1978) 1.04
Duration of rubella immunity induced by two-dose measles, mumps and rubella (MMR) vaccination. A 15-year follow-up in Finland. Vaccine (2000) 1.03
Acute thrombocytopenic purpura following measles, mumps and rubella vaccination. A report on 23 patients. Acta Paediatr (1993) 1.03
Loss of heterozygosity at chromosomes 3, 6, 8, 11, 16, and 17 in ovarian cancer: correlation to clinicopathological variables. Cancer Genet Cytogenet (2000) 1.03
Depletion of CD8+ cells abolishes memory in acquired immunity against Chlamydia pneumoniae in BALB/c mice. Immunology (1999) 1.03
A comparative study of osteomyelitis and purulent arthritis with special reference to aetiology and recovery. Infection (1984) 1.00
The usefulness of C-reactive protein levels in the identification of concurrent septic arthritis in children who have acute hematogenous osteomyelitis. A comparison with the usefulness of the erythrocyte sedimentation rate and the white blood-cell count. J Bone Joint Surg Am (1994) 0.99
Prevalence of diarrheagenic Escherichia coli in finns with or without diarrhea during a round-the-world trip. J Clin Microbiol (2000) 0.99
Antibody responses to four Haemophilus influenzae type b conjugate vaccines. Am J Dis Child (1991) 0.97
Allergic reactions to measles-mumps-rubella vaccination. Pediatrics (2001) 0.97
No measles in Finland. Lancet (1997) 0.97
Neonatal immunization: response to Haemophilus influenzae type b-tetanus toxoid conjugate vaccine. Pediatrics (1995) 0.97
Epidemiology of invasive Haemophilus influenzae type b disease. J Infect Dis (1992) 0.96
C-reactive protein as predictor of sequelae of meningitis. Lancet (1984) 0.95
Epidemiology of rubella in Finland. Euro Surveill (2004) 0.95
Efficacy of salbutamol in treatment of infant pertussis demonstrated by sound spectrum analysis. Lancet (1982) 0.95
Day-to-day reactogenicity and the healthy vaccinee effect of measles-mumps-rubella vaccination. Pediatrics (2000) 0.95
Pharmacodynamics and pharmacokinetics of intramuscular dexmedetomidine. Clin Pharmacol Ther (1992) 0.95
High antibody responses to booster doses of either Haemophilus influenzae capsular polysaccharide or conjugate vaccine after primary immunization with conjugate vaccines. J Infect Dis (1992) 0.95
Secondary prevention of urinary tract infections. The role of trimethoprim alone. Ann Clin Res (1983) 0.94
Immunogenicity of Haemophilus influenzae oligosaccharide-protein and polysaccharide-protein conjugate vaccination of children at 4, 6, and 14 months of age. Pediatrics (1989) 0.94
Systemic Haemophilus influenzae infection in Finland. Clin Pediatr (Phila) (1984) 0.94
Naproxen concentrations in serum, synovial fluid, and synovium. Scand J Rheumatol (1977) 0.94
Rapidity of C-reactive protein in detecting potential septicemia. Pediatr Infect Dis (1983) 0.93
Multivariate prognostication in bacterial meningitis of childhood. Scand J Infect Dis (1987) 0.93
Atipamezole increases medetomidine clearance in the dog: an agonist-antagonist interaction. J Vet Pharmacol Ther (1995) 0.92
C-reactive protein in measles. J Trop Pediatr (1992) 0.91
Tamoxifen and toremifene concentrations in plasma are greatly decreased by rifampin. Clin Pharmacol Ther (1998) 0.91
Pharmacokinetics of naproxen in subjects with normal and impaired renal function. Eur J Clin Pharmacol (1980) 0.91
Factors predicting peri- and neonatal outcome in diabetic pregnancy. Early Hum Dev (2000) 0.90
Length of prediagnostic history related to the course and sequelae of childhood bacterial meningitis. Pediatr Infect Dis J (1993) 0.90